NIAMS Clinical Trial Planning Cooperative Agreement (U34) | Apply Online

Opportunity Summary:

The NIAMS Clinical Trial Planning Cooperative Agreement (U34) is a National Institutes of Health (NIH) funding opportunity from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) that is meant to help investigators get a clinical interventional trial fully planned and ready to launch. Instead of paying for the actual conduct of a clinical trial, this cooperative agreement focuses on the up front work that has to be done before a trial can responsibly begin, such as refining the study design, finalizing operational plans, and preparing the required documentation. The goal is to reduce avoidable delays and problems during implementation by making sure the proposed trial is truly feasible, well designed, and operationally ready.

This announcement supports a U34, which NIH uses as a clinical trial planning mechanism. In practical terms, it is a planning grant that funds the critical preparatory phase for an investigator-initiated clinical intervention study. Applicants are expected to develop a hypothesis-driven trial that aligns with NIAMS mission areas, meaning it must be focused on arthritis, musculoskeletal diseases, and skin diseases (as reflected by the CFDA listing for Arthritis, Musculoskeletal and Skin Diseases Research). NIAMS also emphasizes that the trial needs to be milestone-defined and viewed as a high priority for the Institute, which signals that applicants should be able to justify both scientific importance and public health relevance within NIAMS priorities.

A key feature is that it is a cooperative agreement rather than a standard research grant. That means NIAMS staff are expected to have a more active role than they would under a typical investigator-initiated award. The announcement strongly encourages applicants to consult NIAMS staff before submitting the U34 application. That consultation is important because NIAMS wants the proposed trial concept, scope, and planning milestones to be aligned with what the Institute considers appropriate for this mechanism and worthy of eventual implementation support.

The U34 is positioned as a recommended stepping stone to a later clinical trial implementation application, specifically a U01 implementation cooperative agreement. The expectation is that, after completing the U34 and meeting the agreed-upon milestones, the investigator would be better prepared to submit a U01 application that requests funding to actually run the trial. In other words, the U34 is intended to de-risk and mature a trial proposal so that when it reaches the implementation stage it has a higher chance of success in both peer review and real-world execution.

Financially, the opportunity lists an award ceiling of $250,000, and it states there is no cost sharing or matching requirement. The activity category is Health, and the funding instrument type is a Cooperative Agreement. While the summary does not spell out every allowable cost category, the intent of the mechanism is clear: the funding supports planning, design work, and preparation of the documents and protocols needed for a well-run clinical trial, rather than paying for large-scale participant recruitment and intervention delivery that would occur during the implementation phase.

Eligibility is broad across U.S.-based organizations and includes many types of domestic entities. Eligible applicants include public and private institutions of higher education, nonprofits (including those with 501(c)(3) status and certain nonprofits without it), for-profit organizations other than small businesses, small businesses, state and local governments (including county and city/township governments), independent school districts, special district governments, and certain housing authorities and tribal governments and organizations. The announcement also highlights additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribal colleges and universities, Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions, as well as faith-based or community-based organizations and U.S. territories or possessions. At the same time, it clearly excludes non-U.S. (foreign) institutions and non-U.S. components of U.S. organizations, and it does not allow foreign components as defined by the NIH Grants Policy Statement.

In terms of timing, the opportunity was posted and created on May 1, 2014, with an original and current closing date of March 2, 2015, and an archive date of April 2, 2015. The funding opportunity number is PAR-14-199. The primary public link for the full announcement is provided through the NIH Grants Guide, and the contact listed for technical difficulty accessing or linking to the announcement is the NIH Office of Extramural Research (OER) webmaster.

Overall, this FOA is best understood as NIAMS support for doing the hard preparatory work that separates a promising clinical trial idea from a trial that is genuinely ready to implement. It encourages early coordination with NIAMS, requires a hypothesis-driven and milestone-based plan that fits NIAMS research priorities, and is explicitly connected to a next-step implementation application (U01) that would fund the actual execution of the clinical trial once planning milestones have been completed.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Federal State Marketing Improvement Program

Previous opportunity: NIAMS Clinical Trial Implementation Cooperative Agreement (U01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 14 199

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 14 199) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 14 199", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.